These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3883672)

  • 1. [Treatment of patients with lymphogranulomatosis, stages I and II (preliminary results of a randomized study--radiation and complex therapy)].
    Blokhina NG; Aliev BM; Kruglova GV; Kaverzneva MM; Vasygova NF
    Vestn Akad Med Nauk SSSR; 1985; (1):45-9. PubMed ID: 3883672
    [No Abstract]   [Full Text] [Related]  

  • 2. [3-year results of the combined treatment of stage I and II lymphogranulomatosis patients].
    Baĭsogolov GD; Shakhtarina SV
    Med Radiol (Mosk); 1984 Apr; 29(4):46-50. PubMed ID: 6546966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A combined therapy program for children with lymphogranulomatosis].
    Poliakov VE; Ankudinov VA; Tsygankin VI; Makhonova LA
    Pediatriia; 1984 Feb; (2):34-7. PubMed ID: 6546987
    [No Abstract]   [Full Text] [Related]  

  • 4. [The main stages in the complex treatment of children with lymphogranulomatosis (Hodgkin's disease)].
    Poliakov VE; Tsygankin VI
    Gematol Transfuziol; 1985 Oct; 30(10):38-41. PubMed ID: 3840758
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
    Hagemeister FB; Purugganan R; Fuller L; McLaughlin P; Swan F; Romaguera J; Rodriguez M; Cabanillas F
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):36-43. PubMed ID: 8073308
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The combined therapy of stage-II lymphogranulomatosis: the effect of splenectomy and the time period for achieving full remission on treatment efficacy].
    Demina EA; Kondrat'eva NF; Pirogova NA
    Ter Arkh; 1991; 63(7):40-4. PubMed ID: 1788806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy of treatment using expanded programs of megavolt irradiation and polychemotherapy in patients with lymphogranulomatosis in stages I, II and IIIA].
    Mendeleev IM; Oleĭnik VA; Miasnikov AA; Polezhaev IuN
    Ter Arkh; 1990; 62(7):67-70. PubMed ID: 2123574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the efficacy of radiotherapy in the combined treatment of generalized Hodgkin's disease in children].
    Tsyplenkov VG; Sviridova AV
    Med Radiol (Mosk); 1984 Oct; 29(10):34-7. PubMed ID: 6548787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment procedure in generalized lymphogranulomatosis in children].
    Vialushkin BIa; Koshel' IV; Tsyplenkov VG
    Pediatriia; 1982 Jun; (6):49-52. PubMed ID: 6897112
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of recurrences of Hodgkin's disease in children].
    Armata J; Moryl-Bujakowska A
    Pol Tyg Lek; 1983 Oct 17-24; 38(42-43):1301-4. PubMed ID: 6201835
    [No Abstract]   [Full Text] [Related]  

  • 12. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current methods of treating patients with lymphogranulomatosis, stages I and II].
    Shakhtarina SV
    Vopr Onkol; 1985; 31(8):10-21. PubMed ID: 3898577
    [No Abstract]   [Full Text] [Related]  

  • 15. Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.
    Eich HT; Staar S; Gossmann A; Hansemann K; Skripnitchenko R; Kocher M; Semrau R; Engert A; Josting A; Franklin J; Krug B; Diehl V; Müller RP;
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1121-7. PubMed ID: 15001253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
    Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
    Noordijk EM; Carde P; Dupouy N; Hagenbeek A; Krol AD; Kluin-Nelemans JC; Tirelli U; Monconduit M; Thomas J; Eghbali H; Aleman BM; Bosq J; Vovk M; Verschueren TA; Pény AM; Girinsky T; Raemaekers JM; Henry-Amar M
    J Clin Oncol; 2006 Jul; 24(19):3128-35. PubMed ID: 16754934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
    J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
    Gobbi PG; Pieresca C; Cavanna L; Corbella F; Vallisa D; Federico M; Formisano R; Carotenuto M; Merli F; Callea V; Angrilli F; Silingardi V
    Haematologica; 1996; 81(6):503-12. PubMed ID: 9009437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
    Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.